Literature DB >> 38945

Biochemical discrimination of Hurler and Scheie syndromes.

J J Hopwood, V Muller.   

Abstract

1. Homogenates of cultured skin fibroblasts derived from patients with alpha-L-iduronidase-deficiency disorders (Hurler and Scheie syndromes) were capable of hydrolysing iduronosyl anhydro-[1-3H]mannitol 6-sulphate although at considerably reduced rates compared with normal controls. 2. The Vmax. values of alpha-L-iduronidase from patients with Hurler or Scheie syndromes and from normal controls were 11, 12 and 833 pmol min-1 mg-1 of protein respectively; the corresponding apparent Km values were 656, 50 and 53 mumol/l respectively. The alpha-L-iduronidases from normal and Scheie fibroblast homogenates were shown to exhibit pH optima at 3.6 and 4.1 and were competitively inhibited by both chloride and sulphate ions: Hurler alpha-L-iduronidase activity exhibited the pH optimum at 3.8 and was also inhibited by chloride and to a lesser extent by sulphate ions. 3. The thermal stability of Hurler, Scheie and normal alpha-L-iduronidase activities at 55 degrees C gave half-lives of approximately 1.0, 2.5 and 1.0 h respectively. 4. These biochemical findings clearly demonstrate enzyme differences for these two clinically distinct phenotypes and provide biochemical evidence that the Hurler and Scheie syndromes result from different allelic mutations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38945     DOI: 10.1042/cs0570265

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  20 in total

1.  Neuropathological and clinical correlations in Hurler disease.

Authors:  R W Watts; E Spellacy; J H Adams
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Immunoquantification of the low abundance lysosomal enzyme N-acetylgalactosamine 4-sulphatase.

Authors:  D A Brooks; P A McCourt; G J Gibson; J J Hopwood
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders.

Authors:  Kenneth J Valenzano; Richie Khanna; Allan C Powe; Robert Boyd; Gary Lee; John J Flanagan; Elfrida R Benjamin
Journal:  Assay Drug Dev Technol       Date:  2011-06       Impact factor: 1.738

4.  Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity.

Authors:  J J Hopwood; H Elliott; V J Muller; G T Saccone
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

5.  Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3.

Authors:  H S Scott; L J Ashton; H J Eyre; E Baker; D A Brooks; D F Callen; G R Sutherland; C P Morris; J J Hopwood
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

6.  The mucopolysaccharidoses: biochemistry and clinical symptoms.

Authors:  H Kresse; M Cantz; K von Figura; J Glössl; E Paschke
Journal:  Klin Wochenschr       Date:  1981-08-17

7.  Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.

Authors:  S Fujibayashi; R Minami; Y Ishikawa; K Wagatsuma; T Nakao; S Tsugawa
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 8.  Review: the immunochemical analysis of enzyme from mucopolysaccharidoses patients.

Authors:  D A Brooks
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

10.  alpha-L-iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts.

Authors:  J A Taylor; G J Gibson; D A Brooks; J J Hopwood
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.